Testing JNJ-42756493 (Erdafitinib) as Potentially Targeting Treatment in Cancers With FGFR Mutations or Fusions (MATCH - Subprotocol K2)
Clinical trial NCT06351371 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06351371
- Sponsor
- National Cancer Institute (NCI)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-03
- Primary completion
- 2022-06-02
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.